By News Desk @bactiman63
In August 2020, the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel firmly said of the use of ivermectin: The COVID-19 Treatment Guidelines Panel recommends against the use of ivermectin for the treatment of COVID-19, except in a clinical trial.
Five months later, that same panel changed their recommendation: The COVID-19 Treatment Guidelines Panel has determined that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin for the treatment of COVID-19.
NIH reports since the last revision of the guidelines, the results of several randomized trials and retrospective cohort studies of ivermectin use in patients with COVID-19 have been published in peer-reviewed journals or made available as preliminary, non-peer-reviewed reports. Some clinical studies showed no benefits or worsening of disease after ivermectin use, whereas others reported shorter time to resolution of disease manifestations attributed to COVID-19, greater reduction in inflammatory markers, shorter time to viral clearance, or lower mortality rates in patients who received ivermectin than in patients who received comparator drugs or placebo.
However, most of the studies reported to date had incomplete information and significant methodological limitations, which make it difficult to exclude common causes of bias.
Because of these limitations, the Panel cannot draw definitive conclusions about the clinical efficacy or safety of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin for the treatment of COVID-19.
Ivermectin is an antiparasitic drug that is approved by the Food and Drug Administration (FDA) for the treatment of onchocerciasis and strongyloidiasis. Ivermectin is not FDA-approved for the treatment of any viral infection. In general, the drug is well tolerated. It is currently being evaluated as a potential treatment for COVID-19.
Peru tops 1 million COVID-19 cases, increased restrictions and ivermectin use warning
FDA warning: Ivermectin meant for animals are not for human treatment for COVID-19
That s because their s no money in the drug
That s because their s no money in the drug
now they’ll make it unavailable as well
As of today we have zero cases of Covid 19 here in Sanders County, MT. Thanks to God and Ivermectin 1.87 !! We are on it while FDA is asleep at the wheel. Holly
Ivermectin was used for forty years to treat parasitic infections in humans long before veterinary application.There is bullshit streaming out of the CDC.The antiviral and antiinflammatory effects of ivermectin have been well established.Check out the published info from the National Library of Medicine at the NIH.